269 related articles for article (PubMed ID: 21949735)
1. Cross-protective peptide vaccine against influenza A viruses developed in HLA-A*2402 human immunity model.
Ichihashi T; Yoshida R; Sugimoto C; Takada A; Kajino K
PLoS One; 2011; 6(9):e24626. PubMed ID: 21949735
[TBL] [Abstract][Full Text] [Related]
2. Broadly Protective CD8
Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
J Virol; 2021 May; 95(12):. PubMed ID: 33827939
[TBL] [Abstract][Full Text] [Related]
3. A CTL-based liposomal vaccine capable of inducing protection against heterosubtypic influenza viruses in HLA-A*0201 transgenic mice.
Matsui M; Kohyama S; Suda T; Yokoyama S; Mori M; Kobayashi A; Taneichi M; Uchida T
Biochem Biophys Res Commun; 2010 Jan; 391(3):1494-9. PubMed ID: 20060099
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
5. Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M1
van de Sandt CE; Pronk MR; van Baalen CA; Fouchier RAM; Rimmelzwaan GF
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593036
[TBL] [Abstract][Full Text] [Related]
6. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.
Budimir N; Huckriede A; Meijerhof T; Boon L; Gostick E; Price DA; Wilschut J; de Haan A
PLoS One; 2012; 7(1):e30898. PubMed ID: 22303469
[TBL] [Abstract][Full Text] [Related]
7. Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.
Kreijtz JH; Bodewes R; van den Brand JM; de Mutsert G; Baas C; van Amerongen G; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
Vaccine; 2009 Aug; 27(36):4983-9. PubMed ID: 19538996
[TBL] [Abstract][Full Text] [Related]
8. Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.
Criado MF; Sá E Silva M; Lee DH; Salge CAL; Spackman E; Donis R; Wan XF; Swayne DE
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999029
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin.
Wang B; Yu H; Yang FR; Huang M; Ma JH; Tong GZ
Virol J; 2012 Jun; 9():127. PubMed ID: 22738661
[TBL] [Abstract][Full Text] [Related]
10. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
[TBL] [Abstract][Full Text] [Related]
11. Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses.
Sun Y; Liu J; Yang M; Gao F; Zhou J; Kitamura Y; Gao B; Tien P; Shu Y; Iwamoto A; Chen Z; Gao GF
J Gen Virol; 2010 Apr; 91(Pt 4):919-30. PubMed ID: 19955560
[TBL] [Abstract][Full Text] [Related]
12. Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines.
Tan PT; Heiny AT; Miotto O; Salmon J; Marques ET; Lemonnier F; August JT
PLoS One; 2010 Jan; 5(1):e8754. PubMed ID: 20090904
[TBL] [Abstract][Full Text] [Related]
13. Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine.
De Groot AS; Ardito M; McClaine EM; Moise L; Martin WD
Vaccine; 2009 Sep; 27(42):5740-7. PubMed ID: 19660593
[TBL] [Abstract][Full Text] [Related]
14. A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.
Babon JA; Cruz J; Ennis FA; Yin L; Terajima M
J Virol; 2012 Sep; 86(17):9233-43. PubMed ID: 22718815
[TBL] [Abstract][Full Text] [Related]
15. Cross-allele cytotoxic T lymphocyte responses against 2009 pandemic H1N1 influenza A virus among HLA-A24 and HLA-A3 supertype-positive individuals.
Liu J; Zhang S; Tan S; Yi Y; Wu B; Cao B; Zhu F; Wang C; Wang H; Qi J; Gao GF
J Virol; 2012 Dec; 86(24):13281-94. PubMed ID: 23015716
[TBL] [Abstract][Full Text] [Related]
16. Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein.
Staneková Z; Király J; Stropkovská A; Mikušková T; Mucha V; Kostolanský F; Varečková E
Acta Virol; 2011; 55(1):61-7. PubMed ID: 21434706
[TBL] [Abstract][Full Text] [Related]
17. Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses.
Price GE; Soboleski MR; Lo CY; Misplon JA; Quirion MR; Houser KV; Pearce MB; Pappas C; Tumpey TM; Epstein SL
PLoS One; 2010 Oct; 5(10):e13162. PubMed ID: 20976273
[TBL] [Abstract][Full Text] [Related]
18. Critical role of TLR7 signaling in the priming of cross-protective cytotoxic T lymphocyte responses by a whole inactivated influenza virus vaccine.
Budimir N; de Haan A; Meijerhof T; Waijer S; Boon L; Gostick E; Price DA; Wilschut J; Huckriede A
PLoS One; 2013; 8(5):e63163. PubMed ID: 23658804
[TBL] [Abstract][Full Text] [Related]
19. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus.
Kreijtz JH; de Mutsert G; van Baalen CA; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
J Virol; 2008 Jun; 82(11):5161-6. PubMed ID: 18353950
[TBL] [Abstract][Full Text] [Related]
20. Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses.
Auladell M; Jia X; Hensen L; Chua B; Fox A; Nguyen THO; Doherty PC; Kedzierska K
Front Immunol; 2019; 10():1400. PubMed ID: 31312199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
